+48.2%
GSK vs MOH
-19.7%
+67.9%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MOH | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +2.0% | -2.0% | -0.2% |
| 7D | -3.5% | +1.7% | -5.2% | -3.7% |
| 30D | -3.4% | -0.9% | -2.6% | -3.4% |
| 3M | -8.1% | +5.7% | -13.8% | -8.9% |
| 6M | -11.1% | +39.1% | -50.3% | -14.7% |
| YTD | +0.7% | +17.7% | -16.9% | -2.4% |
| 1Y | +20.1% | +8.4% | +11.8% | +16.9% |
| 3Y | +46.1% | -36.6% | +82.7% | +51.5% |
| All | +48.2% | -19.7% | +67.9% | +47.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MOH.
Daily Out/Under-Performance
Portfolio return minus MOH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MOH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MOH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling